Brief: AnGes: Files For Japan Approval Of Premature Aging Treatment Zokinvy
Table: Anges -Q1 group results
Table: Anges -2022 group results
Table: Anges -2022 parent results
Table: Anges - 9-MTH group results
Brief: Anges Halting Development Of Coronavirus Vaccine For Earlier Variant, Starting For Omicron Ba-5 Variant
Table: Anges - 6-MTH group results
Brief: Eiger BioPharmaceuticals And AnGes Enter Partnership For Lonafarnib In Japan
Table: Anges -Q1 group results
Table: Anges -2021 group results
Table: Anges -2021 parent results
Table: Anges - 9-MTH group results
Table: Anges - 6-MTH group results
Table: Anges -Q1 group results
Table: Anges -Q1 group results
Japan's KM Biologics begins clinical trial of COVID-19 vaccine candidate
Table: Anges -2020 group results
Table: Anges -2020 parent results
Brief: EmendoBio Says Acquired By AnGes